Gladstone NOW: The Campaign Join Us on the Journey ✕
16 - 22 of 22 Results Clear All
Katerina Akassoglou is calling for a fundamental change in the way scientists approach neurological disorders. Her research on the brain’s vascular and immune systems has led to new insights about multiple sclerosis and other conditions.
Multiple Sclerosis Akassoglou Lab
A new study from the Gladstone Institutes shows that a single drop of blood in the brain is sufficient to activate an autoimmune response akin to multiple sclerosis (MS).
Akassoglou Lab Multiple Sclerosis
Finding could have implications for other autoimmune disorders, such as type I diabetes.
Multiple Sclerosis Diabetes
Katerina Akassoglou is working to identify a biomarker that could track the progression of multiple sclerosis using blood tests
Akassoglou Lab Multiple Sclerosis
SAN FRANCISCO, CA—For some, the disease multiple sclerosis (MS) attacks its victims slowly and progressively over a period of many years. For others, it strikes without warning in fits and starts.
Akassoglou Lab Neurological Disease Multiple Sclerosis
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)—a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord.
Akassoglou Lab Multiple Sclerosis
SAN FRANCISCO, CA—The Gladstone Institutes and the international pharmaceutical company H. Lundbeck A/S have announced a collaborative research agreement to study and identify therapeutic candidates for neurological diseases.
Akassoglou Lab Multiple Sclerosis
